SONAR: Study of Diabetic Nephropathy with Atrasentan. A Randomized, Multi-country, Multi-center, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.
Aijaz Gundroo, MD Principal Investigator
Rocco C. Venuto, MD Sub-investigator
The Department of Medicine’s Division of General Internal
Medicine had a strong showing at the 2017 Society of General
Internal Medicine (SGIM) annual meeting with 11 research posters
and one oral presentation.
Researchers at the Hunter James Kelly Research Institute at the
University at Buffalo report on research that illuminates what
causes some kinds of neuropathy and may reveal potentially powerful